Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
出版年份 2019 全文链接
标题
Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot
作者
关键词
-
出版物
Science Translational Medicine
Volume 11, Issue 512, Pages eaaw3163
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2019-10-03
DOI
10.1126/scitranslmed.aaw3163
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak
- (2019) L. E. Kafetzopoulou et al. SCIENCE
- Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model
- (2018) Markus H Kainulainen et al. JOURNAL OF INFECTIOUS DISEASES
- A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
- (2018) Xavier Carnec et al. JOURNAL OF VIROLOGY
- Measles-derived vaccines to prevent emerging viral diseases
- (2018) Phanramphoei N. Frantz et al. MICROBES AND INFECTION
- Properdin: A multifaceted molecule involved in inflammation and diseases
- (2018) Jin Y. Chen et al. MOLECULAR IMMUNOLOGY
- Nigeria hit by unprecedented Lassa fever outbreak
- (2018) Leslie Roberts SCIENCE
- Lassa fever–induced sensorineural hearing loss: A neglected public health and social burden
- (2018) Elizabeth J. Mateer et al. PLoS Neglected Tropical Diseases
- Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
- (2018) Emil C Reisinger et al. LANCET
- Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
- (2018) Tiago Abreu-Mota et al. Nature Communications
- Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells
- (2018) Justine Schaeffer et al. PLoS Pathogens
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
- (2017) Chad E Mire et al. NATURE MEDICINE
- Vaccine platform recombinant measles virus
- (2017) Michael D. Mühlebach VIRUS GENES
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
- (2017) Anne Rechtien et al. Cell Reports
- A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
- (2017) Kathleen A. Cashman et al. Human Vaccines & Immunotherapeutics
- Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance
- (2017) Ashley N. Nelson et al. Scientific Reports
- Vaccine platforms to control Lassa fever
- (2016) Igor S. Lukashevich et al. Expert Review of Vaccines
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
- (2015) Katrin Ramsauer et al. LANCET INFECTIOUS DISEASES
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus
- (2013) Samantha Brandler et al. VACCINE
- Immunogenicity of a recombinant measles HIV-1 subtype C vaccine
- (2013) Richard Stebbings et al. VACCINE
- Camera: a competitive gene set test accounting for inter-gene correlation
- (2012) Di Wu et al. NUCLEIC ACIDS RESEARCH
- Lassa Virus Nucleoprotein Mutants Generated by Reverse Genetics Induce a Robust Type I Interferon Response in Human Dendritic Cells and Macrophages
- (2011) X. Carnec et al. JOURNAL OF VIROLOGY
- Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression
- (2011) K. M. Hastie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
- (2010) Luis M Branco et al. Virology Journal
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
- (2009) R. S. Akondy et al. JOURNAL OF IMMUNOLOGY
- Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles
- (2009) F.-L. Cosset et al. JOURNAL OF VIROLOGY
- MBL2, FCN1, FCN2 and FCN3—The genes behind the initiation of the lectin pathway of complement
- (2009) Peter Garred et al. MOLECULAR IMMUNOLOGY
- Risk Maps of Lassa Fever in West Africa
- (2009) Elisabeth Fichet-Calvet et al. PLoS Neglected Tropical Diseases
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More